Literature DB >> 26026392

High Proportions of People With Nonceliac Wheat Sensitivity Have Autoimmune Disease or Antinuclear Antibodies.

Antonio Carroccio1, Alberto D'Alcamo2, Francesca Cavataio3, Maurizio Soresi2, Aurelio Seidita2, Carmelo Sciumè4, Girolamo Geraci4, Giuseppe Iacono3, Pasquale Mansueto2.   

Abstract

BACKGROUND & AIMS: There is much interest in wheat sensitivity among people without celiac disease (CD), but little is known about any risks associated with the condition. We evaluated the prevalence of autoimmune diseases (ADs) among patients with nonceliac wheat sensitivity (NCWS), and investigated whether they carry antinuclear antibodies (ANA).
METHODS: We performed a retrospective study of 131 patients diagnosed with NCWS (121 female; mean age, 29.1 years) at 2 hospitals in Italy from January 2001 through June 2011. Data were also collected from 151 patients with CD or irritable bowel syndrome (IBS) (controls). Patient medical records were reviewed to identify those with ADs. We also performed a prospective study of 42 patients (38 female; mean age, 34 years) diagnosed with NCWS from July 2011 through March 2014 at 3 hospitals in Italy. One hundred age- and sex-matched subjects with CD or IBS served as controls. Serum samples were collected from all subjects and ANA levels were measured by immunofluorescence analysis. Participants completed a questionnaire and their medical records were reviewed to identify those with ADs.
RESULTS: In the retrospective analysis, similar portions of subjects with NCWS (29%) and CD (29%) developed ADs (mainly Hashimoto's thyroiditis, 29 cases), compared with a smaller proportion of subjects with IBS (4%) (P < .001). In the prospective study, 24% of subjects with NCWS, 20% of subjects with CD, and 2% of subjects with IBS developed ADs (P < .001). In the retrospective study, serum samples tested positive for ANA in 46% of subjects with NCWS (median titer, 1:80), 24% of subjects with CD (P < .001), and 2% of subjects IBS (P < .001); in the prospective study, serum samples were positive for ANA in 28% of subjects with NCWS, 7.5% of subjects with CD (P = .02), and 6% of subjects with IBS (P = .005 vs patients with NCWS). ANA positivity was associated with the presence of the HLA DQ2/DQ8 haplotypes (P < .001).
CONCLUSIONS: Higher proportions of patients with NCWS or CD develop autoimmune disorders, are ANA positive, and showed DQ2/DQ8 haplotypes compared with patients with IBS.
Copyright © 2015 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Celiac Disease; Food Allergy; Gluten Sensitivity; Immune Response

Mesh:

Substances:

Year:  2015        PMID: 26026392     DOI: 10.1053/j.gastro.2015.05.040

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  23 in total

Review 1.  Nonceliac Wheat Sensitivity: An Immune-Mediated Condition with Systemic Manifestations.

Authors:  Umberto Volta; Roberto De Giorgio; Giacomo Caio; Melanie Uhde; Roberto Manfredini; Armin Alaedini
Journal:  Gastroenterol Clin North Am       Date:  2018-12-13       Impact factor: 3.806

2.  Symptomatic improvement with gluten restriction in irritable bowel syndrome: a prospective, randomized, double blinded placebo controlled trial.

Authors:  Vinay G Zanwar; Sunil V Pawar; Pravir A Gambhire; Samit S Jain; Ravindra G Surude; Vinaya B Shah; Qais Q Contractor; Pravin M Rathi
Journal:  Intest Res       Date:  2016-10-17

Review 3.  Intraepithelial lymphocytes, scores, mimickers and challenges in diagnosing gluten-sensitive enteropathy (celiac disease).

Authors:  Consolato Sergi; Fan Shen; Gerd Bouma
Journal:  World J Gastroenterol       Date:  2017-01-28       Impact factor: 5.742

Review 4.  Extra-intestinal manifestations of non-celiac gluten sensitivity: An expanding paradigm.

Authors:  Giuseppe Losurdo; Mariabeatrice Principi; Andrea Iannone; Annacinzia Amoruso; Enzo Ierardi; Alfredo Di Leo; Michele Barone
Journal:  World J Gastroenterol       Date:  2018-04-14       Impact factor: 5.742

5.  Contact Dermatitis Due to Nickel Allergy in Patients Suffering from Non-Celiac Wheat Sensitivity.

Authors:  Alberto D'Alcamo; Pasquale Mansueto; Maurizio Soresi; Rosario Iacobucci; Francesco La Blasca; Girolamo Geraci; Francesca Cavataio; Francesca Fayer; Andrea Arini; Laura Di Stefano; Giuseppe Iacono; Liana Bosco; Antonio Carroccio
Journal:  Nutrients       Date:  2017-02-02       Impact factor: 5.717

Review 6.  Non-Celiac Gluten Sensitivity: An Update.

Authors:  Feliznando Isidro Cárdenas-Torres; Francisco Cabrera-Chávez; Oscar Gerardo Figueroa-Salcido; Noé Ontiveros
Journal:  Medicina (Kaunas)       Date:  2021-05-24       Impact factor: 2.430

7.  Frequency and Clinical Aspects of Neurological and Psychiatric Symptoms in Patients with Non-Celiac Wheat Sensitivity.

Authors:  Antonio Carroccio; Maurizio Soresi; Marta Chiavetta; Francesco La Blasca; Stella Compagnoni; Alessandra Giuliano; Francesca Fayer; Francesca Mandreucci; Daniele Castellucci; Aurelio Seidita; Andrea Affronti; Ada Maria Florena; Pasquale Mansueto
Journal:  Nutrients       Date:  2021-06-08       Impact factor: 5.717

8.  Neurological Dysfunction in Coeliac Disease and Non-Coeliac Gluten Sensitivity.

Authors:  Marios Hadjivassiliou; Dasappaiah G Rao; Richard A Grìnewald; Daniel P Aeschlimann; Ptolemaios G Sarrigiannis; Nigel Hoggard; Pascale Aeschlimann; Peter D Mooney; David S Sanders
Journal:  Am J Gastroenterol       Date:  2016-02-02       Impact factor: 10.864

Review 9.  Dietary Triggers in Irritable Bowel Syndrome: Is There a Role for Gluten?

Authors:  Umberto Volta; Maria Ines Pinto-Sanchez; Elisa Boschetti; Giacomo Caio; Roberto De Giorgio; Elena F Verdu
Journal:  J Neurogastroenterol Motil       Date:  2016-10-30       Impact factor: 4.924

10.  Is perceived intolerance to milk and wheat associated with the corresponding IgG and IgA food antibodies? A cross sectional study in subjects with morbid obesity and gastrointestinal symptoms.

Authors:  Anne Stine Kvehaugen; Dag Tveiten; Per G Farup
Journal:  BMC Gastroenterol       Date:  2018-01-30       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.